OSE Immunotherapeutics SA (EPA:OSE)

OSE Immunotherapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.75	18.67	25.62	33.58	29.37
Cash & Short-Term Investments	16.75	18.67	25.62	33.58	29.37
Cash Growth	-10.32%	-27.12%	-23.70%	14.34%	13.64%
Accounts Receivable	4.14	0.98	0.4	0.77	1.07
Other Receivables	-	6.61	5.98	5.18	5.85
Receivables	4.14	7.59	6.39	5.95	6.92
Prepaid Expenses	-	2.75	3.45	2.96	2.5
Other Current Assets	49.05	1.47	1.74	1.72	1.05
Total Current Assets	69.93	30.48	37.2	44.21	39.83
Property, Plant & Equipment	3.43	4.07	4.98	5.44	3.8
Other Intangible Assets	-	0.14	0.17	0.15	-
Long-Term Deferred Tax Assets	0.19	0.2	0.18	0.17	0.17
Long-Term Deferred Charges	44.01	46.26	48.62	50.97	52.6
Other Long-Term Assets	6.4	0.91	0.64	0.94	0.58
Total Assets	123.96	82.05	91.78	101.88	96.97
Accounts Payable	7.72	9.3	8.54	9.61	10.29
Accrued Expenses	2.67	1.87	2.92	3.72	2.11
Current Portion of Long-Term Debt	7.2	6.4	3.09	1.61	0.05
Current Portion of Leases	0.6	0.86	0.88	0.76	0.59
Current Income Taxes Payable	-	0.02	0.02	0.01	0
Current Unearned Revenue	-	0.35	0.81	1.05	1.09
Other Current Liabilities	2.04	0.01	0	0	0
Total Current Liabilities	20.22	18.8	16.27	16.76	14.13
Long-Term Debt	35.66	35.51	37.23	30.8	16.55
Long-Term Leases	2.68	3.03	3.59	3.97	2.32
Long-Term Unearned Revenue	0.1	-	-	-	-
Long-Term Deferred Tax Liabilities	1.07	1.31	1.51	1.75	2.08
Other Long-Term Liabilities	-	-	0.09	0.29	-
Total Liabilities	60.15	59.08	59.12	53.99	35.61
Common Stock	4.39	4.33	3.71	3.71	3.6
Additional Paid-In Capital	50.92	76.64	65.61	65.61	65.45
Retained Earnings	37.45	-23	-17.76	-16.85	-16.56
Treasury Stock	-0.45	-0.41	-0.55	-0.16	-0.09
Comprehensive Income & Other	-28.49	-34.59	-18.35	-4.41	8.97
Shareholders' Equity	63.81	22.98	32.66	47.89	61.36
Total Liabilities & Equity	123.96	82.05	91.78	101.88	96.97
Total Debt	46.13	45.8	44.79	37.13	19.51
Net Cash (Debt)	-29.39	-27.13	-19.17	-3.55	9.85
Net Cash Growth	-	-	-	-	-31.38%
Net Cash Per Share	-1.16	-1.39	-1.03	-0.20	0.63
Filing Date Shares Outstanding	21.86	21.59	18.45	18.49	17.96
Total Common Shares Outstanding	21.86	21.59	18.46	18.49	17.95
Working Capital	49.71	11.68	20.93	27.45	25.7
Book Value Per Share	2.92	1.06	1.77	2.59	3.42
Tangible Book Value	63.81	22.84	32.49	47.74	61.36
Tangible Book Value Per Share	2.92	1.06	1.76	2.58	3.42
Buildings	-	0.32	0.31	0.36	0.33
Machinery	-	1.67	1.71	1.55	1.3

Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.